Cargando…
Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway
Several members of cucurbitaceae family have been reported to regulate growth of cancer by interfering with STAT3 signaling. In the present study, we investigated the unique role and molecular mechanism of cucurbitacins (Cucs) in reducing symptoms of metabolic syndrome in mice. Cucurbitacin E (CuE)...
Autores principales: | Murtaza, Munazza, Khan, Gulnaz, Aftab, Meha Fatima, Afridi, Shabbir Khan, Ghaffar, Safina, Ahmed, Ayaz, Hafizur, Rahman M., Waraich, Rizwana Sanaullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466318/ https://www.ncbi.nlm.nih.gov/pubmed/28598969 http://dx.doi.org/10.1371/journal.pone.0178910 |
Ejemplares similares
-
Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells
por: Brouwer, Isabella J., et al.
Publicado: (2020) -
Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro
por: Xu, Dongchao, et al.
Publicado: (2022) -
Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways
por: Liu, Yang, et al.
Publicado: (2020) -
STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
por: Oi, Toru, et al.
Publicado: (2016) -
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
por: Boykin, C, et al.
Publicado: (2012)